![]()
A) A skin condition. B) An abnormal growth of tissue in bone. C) A type of blood cell. D) A muscle abnormality.
A) Only from the bone itself. B) From cancers in another part of the body such as lung, breast, thyroid, kidney, and prostate. C) From the liver. D) From the brain.
A) A pathologic fracture. B) A sprained ankle. C) A dislocated shoulder. D) A broken rib.
A) Fatigue, fever, weight loss, anemia, and nausea. B) Blurred vision. C) Hearing loss. D) Coughing and sneezing.
A) By urine color analysis. B) By blood pressure measurement. C) By a physical exam alone. D) By X-ray and other radiological tests such as CT scan, MRI, PET scan, and bone scintigraphy.
A) Hemoglobin A1c. B) Blood sugar levels. C) Cholesterol levels. D) Complete blood count, inflammatory markers, serum electrophoresis, PSA, kidney function, and liver function.
A) Protein levels. B) Glucose. C) Urea. D) Bence Jones protein.
A) A blood transfusion. B) A physical therapy session. C) A dietary consultation. D) A biopsy for histological evaluation.
A) Osteosarcoma. B) Chondrosarcoma. C) Non-ossifying fibroma. D) Ewing sarcoma.
A) 85%. B) 68%. C) 90%. D) 50%.
A) In a rib bone in India. B) In a foot bone in South Africa. C) In a skull bone in China. D) In a hand bone in Egypt.
A) Tumors that originate in the lungs. B) Tumors that originate in the liver. C) Tumors that originate in the brain. D) Tumors that originate in bone or from bone-derived cells and tissues.
A) Tumors that originate in the skin. B) Tumors that originate in other sites and spread to the skeleton. C) Tumors that originate in the kidneys. D) Tumors that originate in the heart.
A) Skin, brain, and ovaries. B) Prostate, breasts, lungs, thyroid, and kidneys. C) Stomach, colon, and bladder. D) Lungs, liver, and pancreas.
A) Osteochondroma. B) Osteosarcoma. C) Chondrosarcoma. D) Ewing sarcoma.
A) Benign tumor. B) Metastatic tumor. C) Hamartoma. D) Bone sarcoma.
A) Distal femur and proximal tibia. B) Spine and pelvis. C) Shoulder and elbow. D) Chest and abdomen.
A) Thrombocytopenia. B) Multiple myeloma. C) Leukemia. D) Lymphoma.
A) In the midline of the sacrum, coccyx, or both. B) In the lungs. C) In the liver. D) In the kidneys.
A) Using only blood tests. B) Using specialized studies like genetic and immunohistochemical tests. C) Using only physical exams. D) Using only X-rays.
A) Ewing sarcoma B) Fibrosarcoma C) Chondrosarcoma D) Osteosarcoma
A) Improved reflexes B) Increased muscle tone C) Neurological signs D) Enhanced coordination
A) They are always benign B) They are rarely ever curable C) They do not require diagnosis D) They are easily treated with medication
A) Oral chemotherapy B) Topical chemotherapy C) Intra-arterial protocol with serial arteriogram D) Intravenous chemotherapy
A) Immediately after chemotherapy starts B) When tumor response is <50% necrosis C) When tumor response has reached >90% necrosis D) After 6 months of treatment
A) Strontium-89 chloride B) Radiotherapy C) Chemotherapy drugs D) Non-hormonal bisphosphonates
A) Radiotherapy B) Joint preservation surgical reconstruction C) Chemotherapy D) Limb amputation
A) Surgical resection B) External beam radiation therapy C) Chemotherapy D) Pain medication
A) The outcome is generally good. B) The outcome is always fatal. C) The outcome is poor. D) The outcome is uncertain.
A) Yes, all benign tumors become cancerous. B) Yes, some types may eventually become malignant. C) No, they remain benign forever. D) No, they never become cancerous.
A) Cure is impossible. B) All patients are cured. C) Cure rate is independent of tumor type, location, and size. D) Most patients achieve a cure, but it depends on various factors.
A) Around 0.2%. B) Around 10%. C) Around 50%. D) Around 5%. |